Literature DB >> 17640971

The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated.

Simon Parry1, Nyet-Kui Wong, Richard L Easton, Maria Panico, Stuart M Haslam, Howard R Morris, Peggy Anderson, Kenneth L Klotz, John C Herr, Alan B Diekman, Anne Dell.   

Abstract

CD52 is composed of a 12 amino acid peptide with N-linked glycans bound to the single potential glycosylation site at position 3, and a glycosylphosphatidylinositol-anchor attached at the C-terminus. Some glycoforms of this molecule expressed in the male reproductive tract are recognized by complement-dependent sperm-immobilizing antibodies in infertile patients making this antigen an important target for immunocontraception and fertility studies. Although the amount of posttranslational modification is already remarkable for such a small polypeptide, O-glycosylation of CD52 has additionally been implicated by several studies, but never rigorously characterized. In this report, we show clear evidence for the presence of O-glycans in CD52 preparations immunopurified using the murine S19 monoclonal antibody generated against sperm agglutination antigen-1 (SAGA-1), a male reproductive tract specific form of CD52. The O-glycans have been characterized by MALDI-TOF and tandem mass spectrometry after reductive elimination and permethylation. The data indicate that the major SAGA-1 O-glycans are core 1 and 2 mucin-type structures, with and without sialic acid (NeuAc(0-2)Hex(1-3)HexNAc(1-2)HexNAcitol). Minor fucosy- lated O-glycans are also present including some struc- tures with putative Le(y) epitopes (NeuAc(0-1)Fuc(1-3)Hex(1-2) HexNAc(0-1)HexNAcitol). Analysis of O-glycopeptides by tandem mass spectrometry provided an additional level of support for the O-glycosylation of SAGA-1. Elucidation of the O-glycosylation of SAGA-1 adds to the complexity of this molecule and may help to explain its biological activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640971     DOI: 10.1093/glycob/cwm076

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  6 in total

1.  Expeditious chemoenzymatic synthesis of CD52 glycopeptide antigens.

Authors:  Wei Huang; Xinyu Zhang; Tongzhong Ju; Richard D Cummings; Lai-Xi Wang
Journal:  Org Biomol Chem       Date:  2010-09-17       Impact factor: 3.876

Review 2.  Sugar-coated sperm: Unraveling the functions of the mammalian sperm glycocalyx.

Authors:  Eillen Tecle; Pascal Gagneux
Journal:  Mol Reprod Dev       Date:  2015-06-09       Impact factor: 2.609

Review 3.  Eukaryotic protein glycosylation: a primer for histochemists and cell biologists.

Authors:  Anthony Corfield
Journal:  Histochem Cell Biol       Date:  2016-12-23       Impact factor: 4.304

4.  Lectin binding of human sperm associates with DEFB126 mutation and serves as a potential biomarker for subfertility.

Authors:  Aijie Xin; Li Cheng; Hua Diao; Yancheng Wu; Shumin Zhou; Changgen Shi; Yangyang Sun; Peng Wang; Shiwei Duan; Jufen Zheng; Bin Wu; Yao Yuan; Yihua Gu; Guowu Chen; Xiaoxi Sun; Huijuan Shi; Shengce Tao; Yonglian Zhang
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

Review 5.  Role of Antisperm Antibodies in Infertility, Pregnancy, and Potential forContraceptive and Antifertility Vaccine Designs: Research Progress and Pioneering Vision.

Authors:  Vickram A S; Kuldeep Dhama; Sandip Chakraborty; Hari Abdul Samad; Shyma K Latheef; Khan Sharun; Sandip Kumar Khurana; Archana K; Ruchi Tiwari; Prakash Bhatt; Vyshali K; Wanpen Chaicumpa
Journal:  Vaccines (Basel)       Date:  2019-09-16

6.  Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52.

Authors:  Abdulrahman M Shathili; Esther Bandala-Sanchez; Alan John; Ethan D Goddard-Borger; Morten Thaysen-Andersen; Arun V Everest-Dass; Timothy E Adams; Leonard C Harrison; Nicolle H Packer
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.